|
| Category | FY | Funding IC | Project Number | Project Title | PI Name | Org Name | State / Country | Amount |
|
HIV/AIDS
|
2014
|
FIC
|
|
NIH Other Funding
|
|
|
|
$2,705,000
|
|
HIV/AIDS
|
2014
|
NCATS
|
|
NIH Other Funding
|
|
|
|
$500,000
|
|
HIV/AIDS
|
2014
|
NCI
|
|
NIH Other Funding
|
|
|
|
$16,080,294
|
|
HIV/AIDS
|
2014
|
NIMHD
|
|
NIH Other Funding
|
|
|
|
$1,526,647
|
|
HIV/AIDS
|
2014
|
NHLBI
|
|
NIH Other Funding
|
|
|
|
$34,880
|
|
HIV/AIDS
|
2014
|
NIAAA
|
|
NIH Other Funding
|
|
|
|
$535,908
|
|
HIV/AIDS
|
2014
|
NIAID
|
|
NIH Other Funding
|
|
|
|
$164,007,946
|
|
HIV/AIDS
|
2014
|
NIAMS
|
|
NIH Other Funding
|
|
|
|
$1,217,901
|
|
HIV/AIDS
|
2014
|
NICHD
|
|
NIH Other Funding
|
|
|
|
$11,501,663
|
|
HIV/AIDS
|
2014
|
NIDA
|
|
NIH Other Funding
|
|
|
|
$19,073,126
|
|
HIV/AIDS
|
2014
|
NIDDK
|
|
NIH Other Funding
|
|
|
|
$18,144
|
|
HIV/AIDS
|
2014
|
NIGMS
|
|
NIH Other Funding
|
|
|
|
$205,000
|
|
HIV/AIDS
|
2014
|
NIMH
|
|
NIH Other Funding
|
|
|
|
$13,365,864
|
|
HIV/AIDS
|
2014
|
NINDS
|
|
NIH Other Funding
|
|
|
|
$19,165,904
|
|
HIV/AIDS
|
2014
|
NINR
|
|
NIH Other Funding
|
|
|
|
$55,859
|
|
HIV/AIDS
|
2014
|
NLM
|
|
NIH Other Funding
|
|
|
|
$7,917,000
|
|
HIV/AIDS
|
2014
|
OD
|
|
NIH Other Funding
|
|
|
|
$32,952,844
|
|
HIV/AIDS
|
2014
|
NIBIB
|
1R03EB015365-01
|
Combined Testing to Identify Virologic Failure and HIV-1 Drug Resistance
|
SMITH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$106,103
|
|
HIV/AIDS
|
2014
|
NIAID
|
1K22AI102769-01
|
Development of Vectored ImmunoProphylaxis as a strategy against HIV
|
BALAZS, ALEJANDRO
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$156,632
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA024549-05
|
Treatment Study Using Depot Naltrexone(2/6)Rhode Island Protocol Treatment Site
|
FRIEDMANN, PETER
|
RHODE ISLAND HOSPITAL
|
RI
|
$332,141
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA024554-05
|
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
|
NUNES, EDWARD
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$264,262
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA026356-05
|
Mechanisms of Nicotine's Behavioral Effects on the HIV-1 Transgenic Rat
|
CHANG, SULIE
|
SETON HALL UNIVERSITY
|
NJ
|
$476,429
|
|
HIV/AIDS
|
2014
|
NIAAA
|
1U01AA021990-01
|
Alcohol and ART Adherence: Assessment, Intervention and Modeling in India
|
SCHENSUL, STEPHEN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$740,949
|
|
HIV/AIDS
|
2014
|
NIAID
|
1R43AI104355-01
|
Targeted Inactivation of the CCR5 HIV Coreceptor with Peptide Nucleic Acids
|
PETERSON-ROTH, ELIZABETH
|
L2 DIAGNOSTICS, LLC
|
CT
|
$250,298
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA025081-05
|
Prescription Drug Abuse in Club Subcultures: Contexts & Risks
|
KELLY, BRIAN
|
PURDUE UNIVERSITY
|
IN
|
$316,946
|
|
HIV/AIDS
|
2014
|
NIDA
|
2T32DA007233-31
|
Behavioral Sciences Training in Drug Abuse Research
|
FALKIN, GREGORY
|
PUBLIC HEALTH SOLUTIONS
|
NY
|
$870,020
|
|
HIV/AIDS
|
2014
|
NICHD
|
5R01HD070720-03
|
Randomized Controlled Trial of ways to improve OVC HIV prevention and well being
|
MURRAY, LAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$451,997
|
|
HIV/AIDS
|
2014
|
NIAID
|
4R37AI021256-29
|
Immunobiology of B Cell Differentiation
|
DORSHKIND, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$385,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
4R37AI051530-12
|
Naive T cell homeostasis: Treg selection and survival
|
BENOIST, CHRISTOPHE
|
HARVARD MEDICAL SCHOOL
|
MA
|
$423,750
|
|
HIV/AIDS
|
2014
|
NIAID
|
4R37AI055332-11
|
Antibody Effector Function in Protection Against HIV-1
|
BURTON, DENNIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$635,370
|
|
HIV/AIDS
|
2014
|
NIAID
|
4R37AI034206-21
|
Self Peptides Bound to MHC Class II In T Cell Selection
|
RUDENSKY, ALEXANDER
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$491,143
|
|
HIV/AIDS
|
2014
|
NIAID
|
4R37AI027690-26
|
HIV-1 reverse transcriptase structure: function, inhibition, and resistance
|
ARNOLD, EDWARD
|
RUTGERS, THE STATE UNIV OF N.J.
|
NJ
|
$774,998
|
|
HIV/AIDS
|
2014
|
NIAID
|
4R37AI048638-14
|
Understanding the Role of Mucosal Antigen Presenting Cells in Regulating Immune R
|
PULENDRAN, BALI
|
EMORY UNIVERSITY
|
GA
|
$446,250
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA033156-02
|
The Impact of Cannabis Use on the Neurocognitive Functioning of Individuals with
|
GONZALEZ, RAUL
|
FLORIDA INTERNATIONAL UNIVERSITY
|
FL
|
$448,623
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA035054-02
|
Randomized Trial of Ibudilast for Methamphetamine Dependence
|
HEINZERLING, KEITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$663,956
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5U24AA020794-04
|
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use
|
JUSTICE, AMY
|
YALE UNIVERSITY
|
CT
|
$752,306
|
|
HIV/AIDS
|
2014
|
NIMH
|
5R01MH100022-03
|
Social-Structural Stressors, Resilience and Sexual Risk Behaviors Among Black Men
|
BOWLEG, INGRID
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$632,795
|
|
HIV/AIDS
|
2014
|
NHGRI
|
7R01HG006882-03
|
Single Molecule Real Time Electronic Sequencing
|
SHEPARD, KENNETH
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$127,747
|
|
HIV/AIDS
|
2014
|
NIDCD
|
1R01DC014369-01
|
Central auditory processing in HIV-positive individuals
|
BUCKEY, JAY
|
DARTMOUTH COLLEGE
|
NH
|
$353,451
|
|
HIV/AIDS
|
2014
|
NIGMS
|
2T32GM008268-26
|
Training in Molecular Biophysics
|
KLEVIT, RACHEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$346,593
|
|
HIV/AIDS
|
2014
|
NIGMS
|
2T32GM007250-39
|
Medical Scientist Training Program
|
HARDING, CLIFFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$752,011
|
|
HIV/AIDS
|
2014
|
NICHD
|
5R01HD074949-02
|
Evaluating a Youth focused economic empowerment approach to HIV Treatment
|
WALDFOGEL, JANE
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$588,481
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068615-08
|
Statistical and Data Management Center (SDMC): Microbicide Trials Network
|
BROWN, ELIZABETH
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$3,387,468
|
|
HIV/AIDS
|
2014
|
NCI
|
2UM1AI068636-08
|
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
|
KURITZKES, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$100,000
|
|
HIV/AIDS
|
2014
|
NHLBI
|
2UM1AI068636-08
|
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
|
KURITZKES, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$500,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068636-08
|
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
|
KURITZKES, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$32,561,815
|
|
HIV/AIDS
|
2014
|
NIDA
|
2UM1AI068636-08
|
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
|
KURITZKES, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$1,000,000
|
|
HIV/AIDS
|
2014
|
NIMH
|
2UM1AI068636-08
|
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
|
KURITZKES, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$8,441
|
|
HIV/AIDS
|
2014
|
NINDS
|
2UM1AI068636-08
|
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
|
KURITZKES, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$1,000,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
1UM1AI106707-01
|
Laboratory Center (LC): Microbicide Trials Network
|
DEZZUTTI, CHARLENE
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
PA
|
$2,644,622
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068613-08
|
LC: HIV Prevention Trials Network
|
ESHLEMAN, SUSAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$5,610,712
|
|
HIV/AIDS
|
2014
|
NIDA
|
2UM1AI068613-08
|
LC: HIV Prevention Trials Network
|
ESHLEMAN, SUSAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$527,399
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068614-08
|
LOC: HIV Vaccine Trials Network
|
COREY, LAWRENCE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$36,427,285
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068619-08
|
LOC: HIV Prevention Trials Network
|
EL-SADR, WAFAA
|
FAMILY HEALTH INTERNATIONAL
|
NC
|
$24,083,646
|
|
HIV/AIDS
|
2014
|
NIDA
|
2UM1AI068619-08
|
LOC: HIV Prevention Trials Network
|
EL-SADR, WAFAA
|
FAMILY HEALTH INTERNATIONAL
|
NC
|
$1,429,879
|
|
HIV/AIDS
|
2014
|
NIAID
|
1UM1AI106701-01
|
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3
|
COOMBS, ROBERT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$6,366,878
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068633-08
|
Leadership and Operations Center (LOC): Microbicide Trials Network
|
HILLIER, SHARON
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
PA
|
$11,616,606
|
|
HIV/AIDS
|
2014
|
NICHD
|
2UM1AI068633-08
|
Leadership and Operations Center (LOC): Microbicide Trials Network
|
HILLIER, SHARON
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
PA
|
$2,700,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068632-08
|
LOC-IMPAACT Leadership Group
|
NACHMAN, SHARON
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$10,493,228
|
|
HIV/AIDS
|
2014
|
NICHD
|
2UM1AI068632-08
|
LOC-IMPAACT Leadership Group
|
NACHMAN, SHARON
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$4,300,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068634-08
|
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
|
HUGHES, MICHAEL
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$12,701,831
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068616-08
|
SDMC - IMPAACT Leadership Group
|
SHAPIRO, DAVID
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$5,033,216
|
|
HIV/AIDS
|
2014
|
NICHD
|
2UM1AI068616-08
|
SDMC - IMPAACT Leadership Group
|
SHAPIRO, DAVID
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$4,000,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
1UM1AI106716-01
|
LC - IMPAACT Leadership Group
|
ALDROVANDI, GRACE
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
CA
|
$792,962
|
|
HIV/AIDS
|
2014
|
NICHD
|
1UM1AI106716-01
|
LC - IMPAACT Leadership Group
|
ALDROVANDI, GRACE
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
CA
|
$1,900,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068635-08
|
SDMC: HIV Vaccine Trials Network
|
GILBERT, PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$10,240,739
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068617-08
|
SDMC: HIV Prevention Trials Network
|
DONNELL, DEBORAH
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$7,783,090
|
|
HIV/AIDS
|
2014
|
NIDA
|
2UM1AI068617-08
|
SDMC: HIV Prevention Trials Network
|
DONNELL, DEBORAH
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$710,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
2UM1AI068618-08
|
LC: HIV Vaccine Trials Network
|
MCELRATH, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$11,216,519
|
|
HIV/AIDS
|
2014
|
NIAID
|
2R01AI068581-06A1
|
PUBLIC HIV DRUG RESISTANCE DATABASE
|
SHAFER, ROBERT
|
STANFORD UNIVERSITY
|
CA
|
$787,117
|
|
HIV/AIDS
|
2014
|
NICHD
|
1U54AI110398-01A1
|
Collaborative African Genomics Network (CAFGEN)
|
ANABWANI, GABRIEL
|
BOTSWANA BAYLOR CHILD/CLINCAL CTR/EXCELL
|
BOTSW
|
$35,000
|
|
HIV/AIDS
|
2014
|
OD
|
1U54AI110398-01A1
|
Collaborative African Genomics Network (CAFGEN)
|
ANABWANI, GABRIEL
|
BOTSWANA BAYLOR CHILD/CLINCAL CTR/EXCELL
|
BOTSW
|
$200,000
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Administrative Core
|
NELSON, STEVE
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$323,175
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Research Component 1
|
VEAZEY, RONALD
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$200,691
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Research Component 2
|
AMEDEE, ANGELA
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$74,171
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Research Component 3
|
KOLLS, JAY
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$113,142
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Research Component 4
|
ZHANG, PING
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$99,461
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Research Component 5
|
MOLINA, PATRICIA
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$108,123
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Animal Core
|
BAGBY, GREGORY
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$333,848
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Laboratory Core
|
ZHANG, PING
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$208,330
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Translational Research/Education Component
|
THEALL, KATHERINE
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$87,609
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5P60AA009803-21
|
Pilot Project Component
|
BAGBY, GREGORY
|
LOUISIANA STATE UNIV-UNIV OF NEW ORLEANS
|
LA
|
$1
|
|
HIV/AIDS
|
2014
|
NIAID
|
2R01AI041239-16A1
|
Fc receptor/Ig interactions and trafficking
|
BJORKMAN, PAMELA
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$416,250
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI098616-03
|
Improved HIV Assays by Combining Four Innovations in Nucleic Acid Chemistry
|
BENNER, STEVEN
|
FOUNDATION FOR APPLIED MOLECULAR EVOLUTN
|
FL
|
$370,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI091476-04
|
Therapeutic use of an enhanced form of CD4-Ig
|
FARZAN, MICHAEL
|
SCRIPPS FLORIDA
|
FL
|
$955,860
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI095098-04
|
KIR and MHC Class I Immunogenetics in SIV Infection
|
EVANS, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$422,290
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI096869-03
|
Regulation of Virulence of Cryptococcus neoformans
|
MADHANI, HITEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$386,250
|
|
HIV/AIDS
|
2014
|
NIDCR
|
5R01DE021223-04
|
Oral immunization against HIV/AIDS with prime-boost strategies
|
HU, SHIU-LOK
|
UNIVERSITY OF WASHINGTON
|
WA
|
$764,999
|
|
HIV/AIDS
|
2014
|
NIDCR
|
5R01DE021273-04
|
Attenuated RhCMV Delta 10 SIV Oral Vaccine Vectors Encoding TLR5 Ligand Sequences
|
SPARGER, ELLEN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$645,317
|
|
HIV/AIDS
|
2014
|
NIDCR
|
5R01DE021291-04
|
Efficacy of Oral CMV/SIV Vectors
|
PICKER, LOUIS
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$1,072,161
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI056045-09
|
Uncovering the Regulatory Role of gH/gL in HSV Fusion
|
EISENBERG, ROSELYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$400,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI047798-14
|
PLASMEPSIN V FUNCTION IN MALARIA PARASITES
|
GOLDBERG, DANIEL
|
WASHINGTON UNIVERSITY
|
MO
|
$157,500
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI072204-07
|
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
|
DIAZ, ANGELA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$816,216
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI097629-03
|
Vaccine-mediated Targeting of Viral IL10 to Control HCMV Shedding and Reinfection
|
BARRY, PETER
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$629,713
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI037113-17
|
Structure-Function Studies & Molecular Interactions of Chemokines
|
HANDEL, TRACY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$387,500
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI093981-03
|
Novel Mucosa-homing Dendritic Cell: Development, Trafficking and Function
|
BUTCHER, EUGENE
|
PALO ALTO VETERANS INSTIT FOR RESEARCH
|
CA
|
$347,500
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI097012-03
|
Mode of action of a new Tat HIV-1 inhibitor
|
VALENTE, SUSANA
|
SCRIPPS FLORIDA
|
FL
|
$678,760
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI103440-02
|
A molecular basis for control of T cell memory
|
HEDRICK, STEPHEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$465,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI104384-02
|
Defining BCR evolution during immunization
|
STAMATATOS, LEONIDAS
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$909,731
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA032260-03
|
Family Therapy via Video Teleconference for Substance-Abusing Rural Adolescents
|
OZECHOWSKI, TIMOTHY
|
OREGON RESEARCH INSTITUTE
|
OR
|
$655,349
|
|
HIV/AIDS
|
2014
|
NIMH
|
5R01MH084794-05
|
Memory Functioning in Children and Adolescents with Perinatal HIV Infection
|
NICHOLS, SHARON
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$393,041
|
|
HIV/AIDS
|
2014
|
NIMH
|
5P01MH070306-10
|
Core A - Admin Core
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$120,951
|
|
HIV/AIDS
|
2014
|
NIMH
|
5P01MH070306-10
|
Core B - database/statistical core
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$142,836
|
|
HIV/AIDS
|
2014
|
NIMH
|
5K23MH094250-03
|
Enhancing HIV screening Among Primary care physicians in the Southeast
|
WHITE, BECKY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$180,407
|
|
HIV/AIDS
|
2014
|
NIMH
|
5P01MH070306-10
|
Core C - Animal Core
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$228,787
|
|
HIV/AIDS
|
2014
|
NIMH
|
5P01MH070306-10
|
Core D - BSL3/Flow Cytometry Core
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$196,323
|
|
HIV/AIDS
|
2014
|
NIMH
|
5P01MH070306-10
|
Project 1 - Analysis & Elimination of non-CNS Reservoirs
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$226,616
|
|
HIV/AIDS
|
2014
|
NIMH
|
5P01MH070306-10
|
Project 2 - Initiation of HAART, HIV Latency & Residual Virus Replication in CNS
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$218,621
|
|
HIV/AIDS
|
2014
|
NIMH
|
5P01MH070306-10
|
Project 3 - Effects of Early HAART on Immune Preservation & CNS Disease
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$208,048
|
|
HIV/AIDS
|
2014
|
NIMH
|
5P01MH070306-10
|
Project 4 - HAART & PNS Toxicity
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$225,546
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI065361-08
|
Vpu inhibits NK cell function through down regulation of NTB-A
|
BARKER, EDWARD
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$336,327
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI087452-06
|
Molecular basis of myelomonocytic receptor function in HIV-1 infection
|
SUNDBERG, ERIC
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$384,615
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI093319-04
|
Antifibrotic Therapy to Improve Immune reconstitution in HIV
|
SCHACKER, TIMOTHY
|
UNIVERSITY OF MINNESOTA
|
MN
|
$610,166
|
|
HIV/AIDS
|
2014
|
NHGRI
|
5U54HG003079-11
|
A Platform for Large-Scale Genomic Discovery
|
WILSON, RICHARD
|
WASHINGTON UNIVERSITY
|
MO
|
$1,023,575
|
|
HIV/AIDS
|
2014
|
NIMH
|
5K24MH093225-04
|
Positive Affect Regulation for HIV Prevention in People with Mood Disorders
|
MOSKOWITZ, JUDITH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$142,459
|
|
HIV/AIDS
|
2014
|
NIMH
|
5R01MH093271-04
|
Regulation of HIV-1 by Rad51 in CNS cells
|
KHALILI, KAMEL
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$382,500
|
|
HIV/AIDS
|
2014
|
NIMH
|
5F30MH096664-03
|
Psychosocial Barriers to Engagement in Care in Young South African Women with HIV
|
CHOLERA, RUSHINA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$37,325
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI062428-09
|
Antiviral CTL mobilization to the genital mucosa
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$727,771
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI076168-06
|
D-peptide Inhibitors of HIV-1 Entry
|
KAY, MICHAEL
|
UNIVERSITY OF UTAH
|
UT
|
$372,500
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI092573-04
|
Drug targets in Mtb Gluconeogenesis
|
EHRT, SABINE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$607,211
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI094745-03
|
B cells and humoral immunity in tuberculosis
|
CHAN, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
NY
|
$703,554
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI095097-03
|
HIV co-infection and HCV-induced liver fibrosis in vivo
|
SU, LISHAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$370,000
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA026770-05
|
Early-Stage Chronic Kidney Disease in HIV-infected Individuals
|
LUCAS, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$481,934
|
|
HIV/AIDS
|
2014
|
NIDA
|
5K01DA031035-04
|
Sexual Networks, Drugs, and HIV Risk among Men Who Have Sex With Men
|
TIEU, HONG VAN
|
NEW YORK BLOOD CENTER
|
NY
|
$168,456
|
|
HIV/AIDS
|
2014
|
NHGRI
|
5U54HG003067-12
|
Large Scale Sequencing and Analysis of Genomes
|
LANDER, ERIC
|
BROAD INSTITUTE, INC.
|
MA
|
$1,292,041
|
|
HIV/AIDS
|
2014
|
NHGRI
|
5U54HG003273-11
|
The Human Genome Sequencing Center
|
GIBBS, RICHARD
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$765,654
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI064909-07
|
TRAF6 and the Fate of CD8 T Cells
|
CHOI, YONGWON
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$400,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI095178-03
|
T cell immunity to Plasmodium sporozoite immunization
|
HARTY, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$599,499
|
|
HIV/AIDS
|
2014
|
NCI
|
5R01CA085180-13
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$680,363
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI058828-09
|
Role of Vpu in Retroviral Particle Assembly
|
SPEARMAN, PAUL
|
EMORY UNIVERSITY
|
GA
|
$387,500
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R13AI093188-04
|
HIV DART: Frontiers in Drug Development for Antiretroviral Therapies
|
SCHINAZI, RAYMOND
|
INFORMED HORIZONS, LLC
|
GA
|
$1
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI097059-03
|
Macrophages in the pathogenesis of AIDS
|
KURODA, MARCELO
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$817,150
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI100873-02
|
Role of transcription coactivator OCA-B in gene poising and immunological memory.
|
TANTIN, DEAN
|
UNIVERSITY OF UTAH
|
UT
|
$372,500
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI103280-02
|
FOSMIDOMYCIN RESISTANCE IN PLASMODIUM FALCIPARUM
|
ODOM, AUDREY
|
WASHINGTON UNIVERSITY
|
MO
|
$342,000
|
|
HIV/AIDS
|
2014
|
NCI
|
5R01CA138811-05
|
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
|
RAAB-TRAUB, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$143,847
|
|
HIV/AIDS
|
2014
|
NIMH
|
5R21MH099944-02
|
Adiponectin replacement Therapy for HAND?
|
BRUCE-KELLER, ANNADORA
|
LSU PENNINGTON BIOMEDICAL RESEARCH CTR
|
LA
|
$222,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI087181-05
|
Broadly Neutralizing Monoclonal Antibodies Against HIV-1
|
LEWIS, GEORGE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$547,121
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI091790-04
|
Biotin synthesis and biotin ligation in Mtb
|
SCHNAPPINGER, DIRK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$605,531
|
|
HIV/AIDS
|
2014
|
OD
|
5P40OD012217-27
|
CARIBBEAN PRIMATE RESEARCH CENTER
|
MARTINEZ, MELWEEN
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$2,196,299
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R37AI051164-12
|
Methods to Advance the HIV Prevention Research Agenda
|
DEGRUTTOLA, VICTOR
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$403,750
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI085043-05
|
Mechanisms of Viral Persistence
|
BROOKS, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$376,165
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI033774-20
|
Protective antibodies for Cryptococcal Infections
|
CASADEVALL, ARTURO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
NY
|
$410,850
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI066121-07
|
IL-27 in Vaccine-Elicited Cellular Immunity
|
KEDL, ROSS
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$381,042
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R21DA033924-02
|
Cocaine enhances HIV replication by inducing transcriptionally active chromatin s
|
TYAGI, MUDIT
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$237,750
|
|
HIV/AIDS
|
2014
|
NIDA
|
5K99DA033878-02
|
Opiate drug abuse & HIV-induced excitotoxicity in striatal neurons
|
FITTING, SYLVIA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$110,190
|
|
HIV/AIDS
|
2014
|
NCI
|
5R01CA117830-09
|
Regulation of KSHV Latency
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
PA
|
$309,287
|
|
HIV/AIDS
|
2014
|
NIMHD
|
5R01MD004075-05
|
Reducing Risk of HIV/STD Infection Among African American Men
|
JEMMOTT, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$396,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI096966-02
|
Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
|
CONNICK, ELIZABETH
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$716,691
|
|
HIV/AIDS
|
2014
|
NCI
|
5R01CA034722-30
|
Products of the Transforming Genes of Polyomavirus
|
SCHAFFHAUSEN, BRIAN
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$160,050
|
|
HIV/AIDS
|
2014
|
NCI
|
5R01CA081135-16
|
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7
|
MUNGER, KARL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$284,258
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA030257-04
|
Delivering HIV Risk Reduction Services in Drug Court
|
FESTINGER, DAVID
|
TREATMENT RESEARCH INSTITUTE
|
PA
|
$437,702
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI049104-13
|
TAT Transactivation
|
PETERLIN, BORIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$386,250
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI064768-09
|
Biology of lipoamide dehydrogenase and 2-hydroxy-3-oxoadipate synthase in Mtb
|
NATHAN, CARL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$920,600
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R13AI068368-09
|
The Palm Springs Symposia on HIV/AIDS
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$20,000
|
|
HIV/AIDS
|
2014
|
NIAAA
|
5R01DA028763-05
|
Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study
|
TEPLIN, LINDA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$177,153
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA028763-05
|
Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study
|
TEPLIN, LINDA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$1,971,010
|
|
HIV/AIDS
|
2014
|
NIAID
|
5F32AI104334-02
|
Structure activity and structure property relationships for novel anti-HIV agents
|
FREY, KATHLEEN
|
YALE UNIVERSITY
|
CT
|
$51,530
|
|
HIV/AIDS
|
2014
|
NIAID
|
5F32AI104380-02
|
The Role of Transcriptional Noise in the Establishment of HIV-1 Latency
|
DAR, ROY
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$53,282
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI098472-03
|
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials
|
GANDHI, MONICA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$538,824
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI044616-16
|
Computer-Aided Design of Anti-HIV Drugs
|
JORGENSEN, WILLIAM
|
YALE UNIVERSITY
|
CT
|
$416,250
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R37AI063928-08
|
Gamma-2 Herpesviruses as Vaccine Vectors for AIDS
|
DESROSIERS, RONALD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$530,253
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI072117-07
|
Regulation of CD8 immunity to intracellular infections
|
GOLDRATH, ANANDA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$310,000
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA013137-14
|
HIV/Cocaine Neurotoxicity in Females
|
BOOZE, ROSEMARIE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$362,500
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R13DA030822-04
|
Academic and Health Policy Conference on Correctional Health Care
|
FERGUSON, WARREN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$42,840
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R24HL085794-08
|
Center for Fetal Gene Transfer for Heart, Lung, and Blood Diseases
|
TARANTAL, ALICE
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$10,000
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI096962-03
|
HIV Infection of Hematopoietic Progenitor Cells
|
COLLINS, KATHLEEN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$579,304
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Senior Leadership
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$56,640
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Leaders of Scientific Research Programs
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$49,431
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Developmental Funds
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$59,502
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Program Planning
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$8,700
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Molecular and Cell Biology Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$35,393
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Administrative Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$83,936
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Bioreagent and Cell Culture Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$16,933
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Flow Cytometry Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$9,830
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Molecular Genomics Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$48,280
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Cell and Tissue Imaging Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$19,927
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Small Animal Imaging Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$12,242
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Translational Pathology Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$82,125
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Biostatistics Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$98,307
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Cancer Research Informatics Core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$17,162
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Clinical Investigations
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$51,014
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Protocol Review and Monitoring System
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$20,287
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Protocol Specific Research Support
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$28,546
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Data And Safety Monitoring
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$18,719
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA014089-39
|
Transgenic and Knockout Mouse core
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$15,332
|
|
HIV/AIDS
|
2014
|
NIMH
|
5R36MH096615-02
|
THE ROLE OF RELIGION ON HIV/AIDS STIGMA MANIFESTATIONS AMONG PUERTO RICANS NURSES
|
REYES-ESTRADA, MARCOS
|
PONCE SCHOOL OF MEDICINE
|
PR
|
$39,995
|
|
HIV/AIDS
|
2014
|
NCI
|
5R01CA142723-05
|
Mechanism of Brd4-mediated papillomavirus host interactions
|
YOU, JIANXIN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$124,952
|
|
HIV/AIDS
|
2014
|
NIMHD
|
5R24MD008064-02
|
CBPR to Reduce Adolescent Pregnancy and HIV in a DC Public Housing Community
|
POPKIN, SUSAN
|
URBAN INSTITUTE
|
DC
|
$364,521
|
|
HIV/AIDS
|
2014
|
NIMH
|
5F31MH099988-02
|
Optimizing Mechanisms for Identifying Older Children with Undiagnosed HIV-1
|
WAGNER, ANJULI
|
UNIVERSITY OF WASHINGTON
|
WA
|
$40,051
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI087164-05
|
Gene expression biomarkers of immune recovery in HIV infected patients
|
RICHMAN, DOUGLAS
|
VETERANS MEDICAL RESEARCH FDN/SAN DIEGO
|
CA
|
$350,460
|
|
HIV/AIDS
|
2014
|
NCI
|
5R01CA095318-10
|
Role of B Cells in Murine Gammaherpesvirus-68 Latency
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
GA
|
$320,872
|
|
HIV/AIDS
|
2014
|
NIDA
|
5R01DA033150-03
|
PDGF-BB Reverses Impaired Neurogenesis Mediated by Tat and Cocaine
|
BUCH, SHILPA
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$334,125
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI068041-08
|
IFN-y-inducible GBPs in protective immunity to tuberculosis
|
MACMICKING, JOHN
|
YALE UNIVERSITY
|
CT
|
$424,633
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI102634-02
|
Dynamic strategies for the clinical management of HIV disease
|
HERNAN, MIGUEL
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$563,882
|
|
HIV/AIDS
|
2014
|
NIAID
|
5R01AI103338-02
|
Enhancing Pathogen-specific Memory CD8+ T cell Responses in Vivo
|
LAUVAU, GREGOIRE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
NY
|
$417,500
|
|
HIV/AIDS
|
2014
|
NCI
|
5R01CA080320-15
|
Myc Oncogene Mutations and Polymorphisms in Cancer
|
COLE, MICHAEL
|
DARTMOUTH COLLEGE
|
NH
|
$81,668
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Senior Leadership
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$27,360
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Program Leaders
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$38,938
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Staff Investigators
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$13,888
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Planning and Evaluation
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$9,962
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Developmental Funds
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$44,248
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Cancer Center Administration
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$46,535
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Immunobiology Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,861
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Tumor Biology Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,805
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Tumor Virology Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$9,220
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Cancer Therapeutics Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,861
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Pediatric Oncology Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,861
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Radiobiology & Imaging Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,391
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Melanoma and Cutaneous Malignancies Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$9,268
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Hematologic Malignancies Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,861
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Breast Cancer Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,861
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Tobacco and Environmental Carcinogenesis Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,861
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Cancer Control Program
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$10,844
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
DNA Sequencing
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$15,943
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Flow Cytometry and Cell Sorting Facility
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$20,107
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Genomics Facility
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$24,726
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Proteomics Core
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$17,684
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Transgenic and Chimeric Mouse Facility
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$17,207
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Human Immunology Core
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$18,247
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Small Animal Imaging Core
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$18,145
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Recruitment, Outcomes, and Assessment Resource
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$23,079
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Biomedical Data Coordination Core
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$29,167
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Biostatistics Core Facility
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$31,891
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Clinical Research Unit
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$38,132
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Clinical Cell and Vaccine Production Facility
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$23,902
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016520-38
|
Clinical Imaging Core
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$21,121
|
|
HIV/AIDS
|
2014
|
NEI
|
5R01EY018755-16
|
Herpes Simplex Virus Egress from Cells and Spread into Neuronal Axons
|
JOHNSON, DAVID
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$446,321
|
|
HIV/AIDS
|
2014
|
NIMH
|
5K01MH089729-05
|
Faith-Based HIV Prevention Intervention for African American Mothers & Daughters
|
KAPUNGU, CHISINA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$165,913
|
|
HIV/AIDS
|
2014
|
NIMH
|
5K25MH089851-05
|
Manganese Enhanced Multi-MRI for Murine HIV-1 Associated Neurocognitive Disorders
|
LIU, YUTONG
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$148,356
|
|
HIV/AIDS
|
2014
|
NIMH
|
5K24MH098759-02
|
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition
|
VALCOUR, VICTOR
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$178,528
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Senior Leadership
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$14,633
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Program Leaders
|
XIONG, YUE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$12,546
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Staff Investigators
|
PISANO, ETTA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$7,932
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Planning and Evaluation
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,814
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Developmental Funds
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$22,094
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Cancer Center Administration
|
O'MALLEY, MICHAEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$18,680
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Cancer Cell Biology
|
XIONG, YUE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,173
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Immunology Program
|
TING, JENNY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,186
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Molecular Therapeutics
|
JOHNSON, GARY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,186
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Virology
|
TRAUB, N
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$7,666
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Virology
|
TRAUB, N
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,173
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Cancer Genetics
|
MAGNUSON, T
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,173
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Clinical Research
|
GOLDBERG, RICHARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,466
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Breast Cancer Research
|
CAREY, LISA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,169
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Cancer Prevention and Control
|
CAMPBELL, MARCI
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,174
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Epidemiology
|
OLSHAN, ANDREW
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$8,173
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Animal Histopathology Core Facility
|
ROGERS, ARLIN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$10,399
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Animal Models Core Facility
|
WEISSMAN, BERNARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$14,053
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Small Animal Imaging Core Facility
|
LIN, WEILI
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$10,253
|
|
HIV/AIDS
|
2014
|
NCI
|
5P30CA016086-38
|
Flow Cytometry Core Facility
|
ARNOLD, LARRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$10,860
|
|
|
